Alnylam Pharmaceuticals
ALNY
#637
Rank
S$41.73 B
Marketcap
$322.36
Share price
0.00%
Change (1 day)
62.96%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company